Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 27, 2022 - Issue 4
Submit an article Journal homepage
2,650
Views
2
CrossRef citations to date
0
Altmetric
Review

Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa

Cristina Martinez-Fernandez de la Camaraa Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, John Radcliffe Hospital, Level 5 & 6, West Wing, Headley Way, OX3 9DU, Oxford, UK;b Oxford Eye Hospital, Oxford University Hospitals NHS Trust, John Radcliffe Hospital, West Wing, Headley Way, OX3 9DU, Oxford, UKView further author information
,
Jasmina Cehajic-Kapetanovica Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, John Radcliffe Hospital, Level 5 & 6, West Wing, Headley Way, OX3 9DU, Oxford, UK;b Oxford Eye Hospital, Oxford University Hospitals NHS Trust, John Radcliffe Hospital, West Wing, Headley Way, OX3 9DU, Oxford, UKView further author information
&
Robert E. MacLarena Nuffield Laboratory of Ophthalmology, Department of Clinical Neurosciences, John Radcliffe Hospital, Level 5 & 6, West Wing, Headley Way, OX3 9DU, Oxford, UK;b Oxford Eye Hospital, Oxford University Hospitals NHS Trust, John Radcliffe Hospital, West Wing, Headley Way, OX3 9DU, Oxford, UKCorrespondence[email protected]
View further author information
Pages 431-443 | Received 05 Feb 2021, Accepted 22 Nov 2022, Published online: 23 Dec 2022

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Cristina Martinez-Fernandez de la Camara, Jasmina Cehajic-Kapetanovic & Robert E. MacLaren. (2022) Response: ‘letter to the editor: emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa’. Expert Opinion on Emerging Drugs 27:4, pages 449-450.
Read now
Anastasios Georgiadis, Alexander J. Smith, Michel Michaelides, Stuart Naylor & Alexandria Forbes. (2022) Letter to the editor: ‘Emerging gene therapy products for RPGR-associated X-linked retinitis pigmentosa’. Expert Opinion on Emerging Drugs 27:4, pages 445-447.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.